Liang Mo

Hengyang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

A Palmitoylation-Associated lncRNA Signature as a Prognostic Biomarker and Its Correlation With the Immune Microenvironment in Lung Adenocarcinoma.

A Palmitoylation-Associated lncRNA Signature as a Prognostic Biomarker and Its Correlation With the Immune Microenvironment in Lung Adenocarcinoma.

Journal: Frontiers in bioscience (Landmark edition)

Published: November 15, 2025

KNL1 Regulates Ferroptosis Resistance and Migration in Lung Adenocarcinoma Cells via AMPK-mTOR Signaling.

KNL1 Regulates Ferroptosis Resistance and Migration in Lung Adenocarcinoma Cells via AMPK-mTOR Signaling.

Journal: Oncology research

Published: October 27, 2025

Keap1-binding Loureirin B mitigates steroid-induced osteonecrosis of the femoral head by suppressing ROS-driven osteoclastogenesis.

Keap1-binding Loureirin B mitigates steroid-induced osteonecrosis of the femoral head by suppressing ROS-driven osteoclastogenesis.

Journal: Chinese medical journal

Published: September 28, 2025

Roburic acid inhibits glucocorticoid-induced osteonecrosis of the femoral head associated osteoclast activity via targeting PTP1B.

Roburic acid inhibits glucocorticoid-induced osteonecrosis of the femoral head associated osteoclast activity via targeting PTP1B.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: September 15, 2025

A Single-Component Nanotheranostic Platform for Synchronous Cancer Imaging, Phototherapy, and Immune Activation.

A Single-Component Nanotheranostic Platform for Synchronous Cancer Imaging, Phototherapy, and Immune Activation.

Journal: Luminescence : the journal of biological and chemical luminescence

Published: August 21, 2025

Cajanin transcriptionally disrupts the Siglec15/NFATc1 signaling cascade to attenuate osteoclast fusion and bone resorption.

Cajanin transcriptionally disrupts the Siglec15/NFATc1 signaling cascade to attenuate osteoclast fusion and bone resorption.

Journal: International immunopharmacology

Published: June 15, 2025

Bisabolangelone targets CSF1R to impede osteoclastogenesis and attenuate estrogen-deficiency bone loss.

Bisabolangelone targets CSF1R to impede osteoclastogenesis and attenuate estrogen-deficiency bone loss.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: May 19, 2025

Oxidative stress-related gene PRXL2A may participate in the occurrence and development of steroid-induced osteonecrosis of the femoral head by regulating osteoclast differentiation: A multi-omics analysis.

Oxidative stress-related gene PRXL2A may participate in the occurrence and development of steroid-induced osteonecrosis of the femoral head by regulating osteoclast differentiation: A multi-omics analysis.

Journal: Gene

Published: April 12, 2025

Single-Cell Transcriptome Analyses of Four Pain Related Genes in Osteosarcoma.

Single-Cell Transcriptome Analyses of Four Pain Related Genes in Osteosarcoma.

Journal: Cancer informatics

Published: October 21, 2024

Isovitexin targets SIRT3 to prevent steroid-induced osteonecrosis of the femoral head by modulating mitophagy-mediated ferroptosis.

Isovitexin targets SIRT3 to prevent steroid-induced osteonecrosis of the femoral head by modulating mitophagy-mediated ferroptosis.

Journal: Bone research

Published: July 11, 2024

A natural agent, 5-deoxycajanin, mitigates estrogen-deficiency bone loss via modulating osteoclast-osteoblast homeostasis.

A natural agent, 5-deoxycajanin, mitigates estrogen-deficiency bone loss via modulating osteoclast-osteoblast homeostasis.

Journal: International immunopharmacology

Published: June 05, 2024

The pathomechanism of bone marrow edema in the femoral head necrosis with pericollapse stage.

The pathomechanism of bone marrow edema in the femoral head necrosis with pericollapse stage.

Journal: Scientific reports

Published: January 04, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026